985 results found

Rising tariff rates under the Trump Administration are creating significant financial pressures for importers beyond the duties themselves, particularly through increased customs bond requirements and stricter surety underwriting standards.

The prescriptions drug market is changing. The disparity of prescription drug prices among countries, along with a growing concern about the availability of affordable medicine, has catalyzed the sale of lower-priced drugs outside the authorized distribution channels of branded drug companies.

President Trump has invoked Section 338 of the Tariff Act of 1930 to impose 50% additional tariffs on nearly $20 billion worth of Canadian goods, including USMCA-compliant products, effective August 19, 2026. The tariffs target dairy, alcoholic beverages, and motor vehicle sectors, marking the first use of this trade tool in over 70 years. Companies importing affected Canadian goods face significant duty exposure and must urgently assess their product classifications and sourcing strategies.

Compliance with US antitrust laws requires firms to consider not only conduct that falls within the scope of the Sherman Act and the Clayton Act, but also conduct that may violate the Federal Trade Commission Act (the "Act"), particularly Section 5.

Out of the many immunities and exemptions precluding or limiting the application of antitrust laws in the United States, state action may be the most widely relied upon immunity.

The basic objective of the antitrust laws is to eliminate practices that interfere with free competition.

Brand enforcement efforts are scaling up with increased takedowns, border seizures, and platform cooperation, yet counterfeiting networks persist by quickly reconstituting under new identities. The fundamental challenge lies not in the availability of enforcement tools, but in the absence of a cohesive strategic framework to dismantle these resilient supply chains permanently.

In a much-awaited decision, the Seventh Circuit has taken a broad view of the ability of U.S. courts to hear antitrust cases concerning alleged foreign cartel activity that plaintiffs contend has effects in the U.S.

One of the primary objectives of the Federal Energy Regulatory Commission's Enforcement division is to prevent, or at least punish, manipulation of the energy markets.

The Federal Trade Commission ("FTC") has announced its annual revisions to the dollar jurisdictional thresholds in the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"); the revised thresholds will become effective 30 days after the date of their publication in the Federal Register.

On January 15, 2015, the Federal Trade Commission announced the annual threshold adjustments for premerger filings under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. § 18a) ("HSR").

Once completely obscure, fidget spinners are now a thing. Meaning that their existence, if not their actual purpose, has become known to you.

For the past several years, US courts have been struggling to articulate the limitations imposed by Section 2 of the Sherman Act on dominant firms seeking to engage in "bundling."

Three recent events indicate that the Obama Administration plans an increased focus on competition issues affecting US agriculture markets.

This is the seventh issue of WilmerHale's 8-in-8 Recent Trends in European Law and Policy Alert Series. Our attorneys will share insights on current and emerging issues affecting companies doing business in Europe and across the Atlantic. Attorneys from across various practice groups at the firm will offer their take on issues ranging from Brexit to Big Data to EU energy market regulation.

Antitrust and trade regulation updates from the European Union, Around the World and the United States

The Federal Trade Commission's ("FTC") new Combating Auto Retail Scams Trade Regulation Rule, known as the CARS Rule (the "Rule"), is a comprehensive initiative aimed at bringing transparency...

Clinical integration of independent health care providers has the potential to create significant benefits for practitioners and patients, in terms of both treatment and costs.